LightLab Imaging, Inc., Announces CE Mark Approval for the Helios Occlusion Balloon Catheter for Use with OCT Imaging System

Company Press Release: contact
Craig Kelley, LightLab Imaging 978-399-1000 ckelley@lightlabimaging.com

WESTFORD, Mass. (October 8, 2004) - LightLab Imaging, Inc. announced today that it has received CE Mark approval for the Helios Occlusion Balloon Catheter. This low-pressure occlusion balloon is intended to work in conjunction with the previously approved M2 OCT Imaging system the ImageWireTM imaging probe, providing for the clearing of blood from the imaging field.

"We are extremely pleased with the approval of this catheter," said Dr. Tetsuaki Tanimura, CEO of LightLab. "This system has been proven safe in animal studies and pre-clinical work. We will now be able to offer physicians in Europe a complete system that will provide them with clinical information unavailable through any other imaging modality."

About LightLab Imaging, Inc.
LightLab Imaging, Inc. is a wholly owned subsidiary of Goodman Company Limited, Japan, (Jasdaq: 7535) LightLab Imaging is focused on the development and commercialization of OCT (optical coherence technology), a new high-resolution high-speed imaging modality that uses advanced photonics for imaging and tissue characterization. When fully exploited, this technology has the potential to dramatically change the way physicians, researchers and scientists view and understand the human body to better diagnose and treat disease.

Live Case Using LightLab Imaging OCT System Presented at TCT 2004
WASHINGTON D.C. (September 27, 2004) - One live case demonstration using the M2 OCT Imaging System and Helios Occlusion Balloon delivery catheter (LightLab Imaging, Inc., Westford, MA), performed by Prof. Eberhard Grube at the Siegburg Heart Center, was transmitted into the Coronary Theater at the TCT, where it was viewed by approximately 1,000 physicians, co-medical and industry professionals. OCT in this case clearly showed a rupture in a saphenous vein graft, which was not able to be detected by other intravascular imaging modalities.